Dextera Surgical Inc (NASDAQ:DXTR) shares gapped down before the market opened on Thursday . The stock had previously closed at $0.16, but opened at $0.14. Dextera Surgical shares last traded at $0.13, with a volume of 2545652 shares changing hands.

A number of research firms have commented on DXTR. Ladenburg Thalmann Financial Services began coverage on Dextera Surgical in a research report on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target for the company. Zacks Investment Research downgraded Dextera Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th.

Dextera Surgical (NASDAQ:DXTR) last posted its earnings results on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The business had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.62 million. sell-side analysts expect that Dextera Surgical Inc will post -0.25 EPS for the current fiscal year.

A hedge fund recently raised its stake in Dextera Surgical stock. Broadfin Capital LLC grew its position in shares of Dextera Surgical Inc (NASDAQ:DXTR) by 64.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 987,520 shares of the medical instruments supplier’s stock after acquiring an additional 388,080 shares during the period. Broadfin Capital LLC owned about 11.06% of Dextera Surgical worth $296,000 at the end of the most recent quarter. Institutional investors own 4.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at

About Dextera Surgical

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Receive News & Ratings for Dextera Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc and related companies with's FREE daily email newsletter.